Medistim ASA (STO:MEDIO)

Market Cap	3.34B
Revenue (ttm)	576.25M
Net Income (ttm)	117.25M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	28.51
Forward PE	33.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	520
Average Volume	564
Open	192.50
Previous Close	168.00
Day's Range	192.50 - 197.50
52-Week Range	120.76 - 180.22
Beta	n/a
RSI	63.20
Earnings Date	May 9, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK